PFBT
KYMR icon

Parkside Financial Bank & Trust’s Kymera Therapeutics KYMR Stock Holding History

Parkside Financial Bank & Trust’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.8K Hold
68
– – ﹤0.01% 1744
2026
Q1 		$5.66K Hold
68
– – ﹤0.01% 1782
2025
Q4 		$5.29K Hold
68
– – ﹤0.01% 1781
2025
Q3 		$3.85K Buy
68
+12
+21% +$541 ﹤0.01% 1809
2025
Q2 		$2.44K Buy
+56
New +$1.93K ﹤0.01% 1931

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Parkside Financial Bank & Trust's KYMR Position: Q2 2026 in Review

Parkside Financial Bank & Trust held its Kymera Therapeutics (KYMR) position steady in Q2 2026 at 68 shares worth $7.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Parkside Financial Bank & Trust first reported a position in KYMR in Q2 2025 and has held it in 5 quarters since. 276 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Parkside Financial Bank & Trust held 68 shares of Kymera Therapeutics worth $7.8K as of Q2 2026.
  • Parkside Financial Bank & Trust left its Kymera Therapeutics share count unchanged in Q2 2026.
  • Kymera Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1744 holding.
  • Parkside Financial Bank & Trust first reported a position in Kymera Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 276 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.